John Feore advises healthcare providers, plans, and life sciences companies on the transformation of the healthcare system.

He applies his background as a healthcare regulatory and policy attorney to optimize clients’ understanding of health policy, payment and delivery system reforms, and alternative payment models. John helps clients to navigate the changing healthcare landscape and to develop, implement, and capitalize on new payment and delivery reforms, including accountable care organizations, bundled payment models, and other demonstrations operated by the Center for Medicare & Medicaid Innovation and private payers.

Prior to joining Avalere, John was a senior managing associate at Dentons US LLP, providing strategic counsel to clients regarding the impacts of federal healthcare law, regulations, and legal challenges.

John has a JD from the Catholic University Columbus School of Law and a BA from Boston College. He is a member of the Virginia State Bar and the District of Columbia Bar.

Authored Content

A shifting policy landscape and emerging market forces could introduce significant disruption in the kidney care space in the coming years. Understanding the risks and opportunities that these changes may present will be critical for patients, providers, payers, and manufacturers alike.

Medicare ACOs continue to realize experience-level results.

CMMI’s impact on Medicare spending has so far not reached earlier projections by the Congressional Budget Office, demonstrating the difficulty in projecting savings from new and unknown alternative payment models.

Announced in late April, the Center for Medicare & Medicaid Services’ (CMS) Primary Care First initiative marks a critical step forward in the long and complex journey toward a fundamentally transformed healthcare system.

CMS announced the new CMS Primary Cares Initiative, comprising 5 new payment models under 2 programs, which will test the impact of providing considerable financial incentives and flexibility to primary care practices and organizations in exchange for significant provider risk.

Providers in the Bundled Payments for Care Improvement Advanced initiative began to assume financial risk on March 1, 2019.

Avalere experts hosted a lively discussion on the 2019 outlook for the medical device industry.

ACO Experience Again Proves to Be an Indicator of Success

Assuming risk appears to be a less important factor than experience in predicting ACO success.

Early adoption and participation in an AAPM can provide a higher incentive payment to Medicare clinicians than MIPS.

On April 24, 2018, Avalere experts were joined by Aledade CEO, Farzad Mostashari, MD, to discuss the latest developments coming out of the Center for Medicare & Medicaid Innovation (CMMI).

Avalere experts are joined by Aledade CEO, Farzad Mostashari, MD, discussing the latest developments coming out of the Center for Medicare & Medicaid Innovation (CMMI).

MSSP and CMMI demonstrations vary in budgetary impact but generally show quality improvement.

Incentive payments in upside-only Medicare ACOs have increased federal costs, but data suggest that ACO experience and adoption of two-sided risk could constrain future Medicare costs.

While clinicians have been hesitant to assume risk, bonus payments would result in 9 out of 10 ACOs and their participants achieving a net positive financial impact.

New analysis from Avalere finds that payments to certain physician specialists could increase or decrease by as much as 16% for their 2018 performance under the Merit-based Incentive Payment System (MIPS).

Avalere simulation finds that more ACOs will be eligible for earnings if they take on two-sided risk.

Today, the Centers for Medicare & Medicaid Services (CMS) released the proposed rule that makes changes to the Quality Payment Program (QPP) for 2018, the second year of the program created by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).

The number of CMS-approved QCDRs tied to payment grows by more than 60% in 2017.

As the industry continues to see a shift from volume to value, Avalere experts examine the future of Medicare's Quality Payment Program under a new administration.

In the final episode of our QPP podcast series, Nelly Ganesan, one of our MACRA experts, talks about the Merit-Based Incentive Payment System (MIPS) optimization.

In our second QPP podcast, John Feore, one of our alternative payment experts, talks about the Advanced APM option and its qualifications.

2017 marks the first performance year for providers in the value-based Quality Payment Program (QPP), which implements two new payment models for clinicians who participate in Medicare. Tune in as our experts kick off a podcast series covering: Requirements and payment adjustments under QPP 2017 performance year milestones, qualifying clinicians for Alternative Payment Models (APMs), and optimizing the Merit-Based Incentive Payment System (MIPS).

On January 18, 2017, the Centers for Medicare & Medicaid Services (CMS) announced the new Accountable Care Organization (ACO) participants in the Medicare Shared Savings Program (MSSP) for 2017.

The passage of the Affordable Care Act established the Center for Medicare and Medicaid Innovation (CMMI) to help advance new payment and delivery models.

HHS confirms continued movement away from traditional FFS payments, yet significant work remains to move more providers away from upside-risk models and into downside-risk models.

The Centers for Medicare & Medicaid Services (CMS) announced that 121 new Medicare Accountable Care Organizations (ACOs) have joined the Medicare Shared Savings Program (MSSP) and Next Generation (Next Gen) ACO models. In addition, 147 MSSP ACOs renewed their contracts. The increase in risk-bearing ACOs and the recently released proposed benchmark rule mark CMS' commitment to shifting from volume to value.